Cargando…
Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status
BACKGROUND: To evaluate the diagnostic value of MR imaging for the differentiation of lipomas and atypical lipomatous tumors (ALT) in comparison with histology and MDM2 amplification status. METHODS: Patients with well-differentiated lipomatous tumors (n = 113), of which 66 were diagnosed as lipoma...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448188/ https://www.ncbi.nlm.nih.gov/pubmed/30943944 http://dx.doi.org/10.1186/s12885-019-5524-5 |
_version_ | 1783408648083472384 |
---|---|
author | Knebel, Carolin Neumann, Jan Schwaiger, Benedikt J. Karampinos, Dimitris C. Pfeiffer, Daniela Specht, Katja Lenze, Ulrich von Eisenhart-Rothe, Rüdiger Rummeny, Ernst J. Woertler, Klaus Gersing, Alexandra S. |
author_facet | Knebel, Carolin Neumann, Jan Schwaiger, Benedikt J. Karampinos, Dimitris C. Pfeiffer, Daniela Specht, Katja Lenze, Ulrich von Eisenhart-Rothe, Rüdiger Rummeny, Ernst J. Woertler, Klaus Gersing, Alexandra S. |
author_sort | Knebel, Carolin |
collection | PubMed |
description | BACKGROUND: To evaluate the diagnostic value of MR imaging for the differentiation of lipomas and atypical lipomatous tumors (ALT) in comparison with histology and MDM2 amplification status. METHODS: Patients with well-differentiated lipomatous tumors (n = 113), of which 66 were diagnosed as lipoma (mean age 53 years (range, 13–82); 47% women) and 47 as atypical lipomatous tumor (ALT; mean age 60 years (range, 28–88); 64% women), were included into this study using histology and MDM2 amplification status by fluorescence in situ hybridization (FISH) as standard of reference. Preoperative MR images were retrospectively assessed by two radiologists for the following imaging features: maximum tumor diameter (mm) as well as the affected compartment (intramuscular, intermuscular or subcutaneous), septa (absent, thin (< 2 mm) or thick septa (> 2 mm) with nodular components); contrast enhancing areas within the lipomatous tumor (< 1/3 of the tumor volume, > 1/3 of the tumor volume); RESULTS: Of the 47 patients with ALT, 40 (85.1%) presented thick septa (> 2 mm) and this finding significantly increased the likelihood of ALT (OR 6.24, 95% CI 3.36–11.59; P < 0.001). The likelihood of ALT was increased if the tumor exceeded a maximum diameter of 130.0 mm (OR 2.74, 95% CI 1.82–4.11, P < 0.001). The presence of contrast enhancement in lipomatous tumors significantly increased the likelihood of ALT (Odds ratio (OR) 2.95, 95% confidence interval (CI) 2.01–4.31; P < 0.001). Of the lipomas, 21.1% were located subcutaneously, 63.6% intramuscularly and 15.2% intermuscularly. On the other hand, none of the ALTs were located subcutaneously, the majority was located intermuscularly (87.3%) and a small number of ALTs was located intramuscularly (12.7%). CONCLUSIONS: Our results suggest that using specific morphological MR imaging characteristics (maximum tumor diameter, thick septa and contrast enhancement) and the information on the localization of the lipomatous tumor, a high sensitivity and substantial specificity can be achieved for the diagnosis of lipomas and ALTs. |
format | Online Article Text |
id | pubmed-6448188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64481882019-04-15 Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status Knebel, Carolin Neumann, Jan Schwaiger, Benedikt J. Karampinos, Dimitris C. Pfeiffer, Daniela Specht, Katja Lenze, Ulrich von Eisenhart-Rothe, Rüdiger Rummeny, Ernst J. Woertler, Klaus Gersing, Alexandra S. BMC Cancer Research Article BACKGROUND: To evaluate the diagnostic value of MR imaging for the differentiation of lipomas and atypical lipomatous tumors (ALT) in comparison with histology and MDM2 amplification status. METHODS: Patients with well-differentiated lipomatous tumors (n = 113), of which 66 were diagnosed as lipoma (mean age 53 years (range, 13–82); 47% women) and 47 as atypical lipomatous tumor (ALT; mean age 60 years (range, 28–88); 64% women), were included into this study using histology and MDM2 amplification status by fluorescence in situ hybridization (FISH) as standard of reference. Preoperative MR images were retrospectively assessed by two radiologists for the following imaging features: maximum tumor diameter (mm) as well as the affected compartment (intramuscular, intermuscular or subcutaneous), septa (absent, thin (< 2 mm) or thick septa (> 2 mm) with nodular components); contrast enhancing areas within the lipomatous tumor (< 1/3 of the tumor volume, > 1/3 of the tumor volume); RESULTS: Of the 47 patients with ALT, 40 (85.1%) presented thick septa (> 2 mm) and this finding significantly increased the likelihood of ALT (OR 6.24, 95% CI 3.36–11.59; P < 0.001). The likelihood of ALT was increased if the tumor exceeded a maximum diameter of 130.0 mm (OR 2.74, 95% CI 1.82–4.11, P < 0.001). The presence of contrast enhancement in lipomatous tumors significantly increased the likelihood of ALT (Odds ratio (OR) 2.95, 95% confidence interval (CI) 2.01–4.31; P < 0.001). Of the lipomas, 21.1% were located subcutaneously, 63.6% intramuscularly and 15.2% intermuscularly. On the other hand, none of the ALTs were located subcutaneously, the majority was located intermuscularly (87.3%) and a small number of ALTs was located intramuscularly (12.7%). CONCLUSIONS: Our results suggest that using specific morphological MR imaging characteristics (maximum tumor diameter, thick septa and contrast enhancement) and the information on the localization of the lipomatous tumor, a high sensitivity and substantial specificity can be achieved for the diagnosis of lipomas and ALTs. BioMed Central 2019-04-03 /pmc/articles/PMC6448188/ /pubmed/30943944 http://dx.doi.org/10.1186/s12885-019-5524-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Knebel, Carolin Neumann, Jan Schwaiger, Benedikt J. Karampinos, Dimitris C. Pfeiffer, Daniela Specht, Katja Lenze, Ulrich von Eisenhart-Rothe, Rüdiger Rummeny, Ernst J. Woertler, Klaus Gersing, Alexandra S. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title | Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title_full | Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title_fullStr | Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title_full_unstemmed | Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title_short | Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status |
title_sort | differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with mdm2 gene amplification status |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448188/ https://www.ncbi.nlm.nih.gov/pubmed/30943944 http://dx.doi.org/10.1186/s12885-019-5524-5 |
work_keys_str_mv | AT knebelcarolin differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT neumannjan differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT schwaigerbenediktj differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT karampinosdimitrisc differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT pfeifferdaniela differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT spechtkatja differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT lenzeulrich differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT voneisenhartrotherudiger differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT rummenyernstj differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT woertlerklaus differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus AT gersingalexandras differentiatingatypicallipomatoustumorsfromlipomaswithmagneticresonanceimagingacomparisonwithmdm2geneamplificationstatus |